Dr. David Bargnesi, MD
What this data tells you about Dr. Bargnesi
Dr. David Bargnesi is an urology physician in Orange Park, FL, with 17 years in practice. Based on federal Medicare data, Dr. Bargnesi performed 6,699 Medicare services across 2,441 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bargnesi received a total of $3,863 from 39 pharmaceutical and/or device companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bargnesi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 2,960 | $3 | $10 |
| Manual urinalysis test with examination using microscope, non-automated | 959 | $4 | $10 |
| Office visit, established patient (20-29 min) | 748 | $64 | $287 |
| Office visit, established patient (30-39 min) | 430 | $92 | $406 |
| Simple bladder irrigation and/or instillation | 203 | $39 | $251 |
| Limited ultrasound scan of pelvis | 173 | $35 | $149 |
| Bladder ultrasound after voiding | 148 | $8 | $60 |
| Diagnostic exam of bladder and urethra using an endoscope | 146 | $183 | $739 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 119 | $14 | $70 |
| New patient office visit (30-44 min) | 118 | $78 | $355 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 117 | $134 | $604 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $26 | $101 |
| Fitting and insertion of vaginal support device | 56 | $56 | $237 |
| Initial hospital admission, moderate complexity | 56 | $103 | $427 |
| Injection, garamycin, gentamicin, up to 80 mg | 46 | $2 | $10 |
| Simple insertion of temporary bladder tube | 39 | $44 | $200 |
| Initial hospital admission, high complexity | 38 | $137 | $626 |
| Hospital follow-up visit, low complexity | 32 | $38 | $120 |
| New patient office visit (45-59 min) | 29 | $114 | $530 |
| Ultrasound scan of pelvic region through rectum | 27 | $104 | $430 |
| Electronic assessment of bladder emptying | 26 | $6 | $45 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 24 | $25 | $204 |
| Insertion of device into abdomen with pressure and urine flow rate study | 24 | $142 | $565 |
| Drug injection, under skin or into muscle | 23 | $10 | $44 |
| Ultrasonic guidance for needle placement | 22 | $45 | $182 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 21 | $297 | $1,242 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $52 | $288 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $25 | $175 |
| Biopsy of prostate gland | 14 | $176 | $795 |
| Office visit, established patient (10-19 min) | 11 | $40 | $175 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bargnesi is a clinical cardiology specialist, with above-average Medicare volume (top 18% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bargnesi experienced with injection, degarelix, 1 mg?
Does Dr. Bargnesi receive payments from pharmaceutical companies?
How do Dr. Bargnesi's costs compare to other urology physicians in Orange Park?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology